Centessa Pharmaceuticals's total assets for Q3 2023 were $377.36M, a decrease of -3.96% from the previous quarter. CNTA total liabilities were $117.97M for the fiscal quarter, a 1.43% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.